CVS Fined $1.5 Million by Ohio Over Staffing Issuesnews2024-03-03T19:17:09+00:00March 3rd, 2024|The New York Times|
Gene Therapies Could Transform Rare Diseases. Are We Holding Them Back?news2024-02-19T22:47:36+00:00February 19th, 2024|The New York Times|
Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelmnews2024-01-31T19:10:58+00:00January 31st, 2024|The New York Times|
This Quiet Blockbuster at the Supreme Court Could Impact All Americansnews2023-11-22T13:46:34+00:00November 22nd, 2023|The New York Times|
Amazon to Stop Selling Seven Eyedrops After F.D.A. Warningnews2023-11-15T16:16:27+00:00November 15th, 2023|The New York Times|
Eyedrops From Major Brands May Cause Infection, F.D.A. Saysnews2023-10-29T23:47:48+00:00October 29th, 2023|The New York Times|
FDA Issues Warning Over Misuse of Ketamine Therapynews2023-10-11T20:50:31+00:00October 11th, 2023|The New York Times|
Why It Took So Long for the FDA to Tackle a Cold Medicinenews2023-09-15T22:52:53+00:00September 15th, 2023|The New York Times|
Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Saysnews2023-09-14T18:20:16+00:00September 14th, 2023|The New York Times|
